Articles with the keyword: 
Evidence For Efficacy of PTSD Therapy Is Missing in Action
lihuazhang821003 submitted, created time 1 year 2 months (www.medpagetoday.com)
WASHINGTON, Oct. 19 -- Evidence for the efficacy of most treatments for post-traumatic stress disorder (PTSD) is inconclusive, according to an Institute of Medicine committee.
A review of 90 studies on pharmaceutical and psychiatric interventions for PTSD showed that many studies were flawed or inadequate, making it impossible to draw adequate conclusions on the relative merits of various treatments, with the exception of exposure therapy, said the authors of
Treatment of Posttraumatic Stress Disorder: An Assessment of the Evidence 
Whites take supplemental breast cancer therapy more often than blacks
william submitted, created time 1 year 3 months (www.eurekalert.org)
A new study finds that white women more frequently take more of the life-prolonging supplemental therapies used to treat breast cancer than African-American women.
New therapy could preserve vessel function after heart attack
kitty submitted, created time 1 year 3 months (researchnews.osu.edu)
Scientists have identified the process that causes blood vessels to constrict during and after a heart attack. They've also demonstrated that delivering a vital molecule that is depleted during this process directly to those blood vessels can reverse damage and help restore blood flow.
Normotensive Ischemic Acute Renal Failure
jiangyun submitted, created time 1 year 4 months (content.nejm.org)
Acute renal failure is defined as a rapid decrease in the glomerular filtration rate, occurring over a period of minutes to days. Because the rate of production of metabolic waste exceeds the rate of renal excretion in this circumstance, serum concentrations of markers of renal function, such as urea and creatinine, rise. The causes of acute renal failure are classically divided into three categories: prerenal, postrenal (or obstructive), and intrinsic. Prerenal azotemia is considered a functional response to renal hypoperfusion, in which renal structure and microstructure are preserved
Acrux delivers on male testosterone lotion
bianjie submitted, created time 1 year 5 months (www.biologynews.net)
Listed Australian biotech company Acrux (ASX: ACR) has taken a significant step forward towards becoming a world leader in the simple and effective delivery of male testosterone replacement therapy, following the success of a clinical trial with its innovative testosterone under-arm lotion.
JCI table of contents: July 12, 2007
bianjie submitted, created time 1 year 5 months (www.eurekalert.org)
This release contains summaries, links to PDFs and contact information for the following newsworthy papers to be published online, July 12, 2007, in the JCI, including: "Src inhibitors may prove beneficial in breast cancer therapy"; "The clot thickens: protein interaction is a drug target for blood clot prevention"; "Eap1 in the brain regulates the female reproductive cycle"; and "Which T cell types drive the autoimmune response in multiple sclerosis?"
bianjie submitted, created time 1 year 5 months (www.eurekalert.org)
In this study, clinical responses to antiretroviral drug therapy are simulated for the first time, and the model is then applied to IM therapy.
Gene's activity points to more lethal subtype of AML
bianjie submitted, created time 1 year 5 months (www.biologynews.net)
A new study shows that the activity of a particular gene can identify people who have a more lethal form of acute myeloid leukemia, singling out those patients who should receive more intense therapy.
Scientists follow familiar TRAIL to new cancer therapy
bianjie submitted, created time 1 year 5 months (www.eurekalert.org)
A new study identifies a combination therapy that may sensitize human cancer cells to a promising treatment currently being used in clinical trials. The research, published in the July issue of the journal Cancer Cell, published by Cell Press, provides a pharmacological method for enhancing the potency and effectiveness of a tumor necrosis factor death receptor ligand against a variety of human cancers.
The potential of cardiac stem cell therapy for heart failure
medal submitted, created time 1 year 8 months (www.sciencedirect.com)
"Cardiac failure is characterised by the loss of cardiomyocytes, and several strategies to replace the lost cell mass are being developed. Animal models have demonstrated the therapeutic potential of several cell types, and both autologous skeletal myoblasts and bone marrow progenitor cells have been tested in preliminary clinical trials. However functional improvements have been modest and the mechanism of benefit is unclear, although myocardial regeneration is not a significant factor
danceinrain submitted, created time 1 year 11 months (www.sciam.com)
The first stem cell therapy targeting a major brain disorder, chronic stroke, could begin clinical trials this year if the U.S. Food and Drug Administration approves the request filed in December by stem cell firm ReNeuron in Guildford, England. This latest treatment suggests stem cell therapies are growing not only in number but in ambition.
Chronic stroke, in which patients suffer from permanent infirmity, is the leading cause of adult disability in the developed world
\ 1
\ 
abuse@discover8.com
angelfish
Darkfrog
jane2007
kavin
Sue Wu
DanyC
addict
MBP (1-11) is the major encephalitogenic epitope of the myel ...
www.genscript.com
Rabbit Anti STAT1 (Phospho-Tyr701) (polyclonal)
antibody : Rabbit Anti STAT1 (Phospho-Tyr701) (polyclonal) ...
www.genscript.com
Rabbit Anti p27Kip1 (Phospho-Thr187) (polyclonal)
antibody : Rabbit Anti p27Kip1 (Phospho-Thr187) (polyclonal) ...
www.genscript.com
Rabbit Anti cdc25A (Ab-75) (polyclonal)
antibody : Rabbit Anti cdc25A (Ab-75) (polyclonal)
www.genscript.com